Clinical Trials Directory

Trials / Completed

CompletedNCT03290612

Vitamin C to Reduce Morning Cardiovascular Risk

Chronotherapeutic Use of Vitamin C to Reduce Morning Cardiovascular Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
40 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study will test the efficacy of Vitamin C to counteract morning cardiovascular (CV) risk markers in a randomized, double blind, placebo controlled crossover pilot study. The participants will also perform morning typical behaviors such as arousal from sleep, change in posture (getting out of bed) and mild intensity physical activity; identical to the stressors encountered in everyday life. Primary dependent variables are markers of cardiovascular risk including vascular endothelial function and oxidative stress.

Detailed description

The investigators plan to test the efficacy of Vitamin C to counteract morning cardiovascular (CV) risk markers in a randomized, double blind, placebo controlled crossover pilot study. The participants will also perform morning typical behaviors such as arousal from sleep, change in posture (getting out of bed) and mild intensity physical activity; identical to the stressors encountered in everyday life. This pilot study is in healthy middle aged adults without a history of CV disease. Participants will spend two nights in an inpatient hospital suite at Hatfield Research Center. Upon awakening in the morning, they will either ingest Vitamin C or placebo in a randomized order. This will be followed by moderate intensity exercise, recovery, and discharge.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin C1.5g Ascorbic Acid
OTHERPlaceboInactive placebo to mimic 1.5g ascorbic acid.

Timeline

Start date
2018-02-13
Primary completion
2022-03-01
Completion
2022-03-01
First posted
2017-09-25
Last updated
2023-03-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03290612. Inclusion in this directory is not an endorsement.